Haleon (NYSE:HLN) Earns "Hold" Rating from HSBC

Haleon (NYSE:HLN - Get Free Report)'s stock had its "hold" rating reaffirmed by research analysts at HSBC in a report released on Wednesday, Marketbeat reports.

Other research analysts also recently issued reports about the company. Sanford C. Bernstein downgraded Haleon from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 8th. Morgan Stanley cut shares of Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Five equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Haleon has a consensus rating of "Moderate Buy" and an average target price of $10.95.

Haleon Stock Up 0.5 %

Shares of Haleon stock traded up $0.06 during midday trading on Wednesday, hitting $10.45. The company's stock had a trading volume of 10,381,006 shares, compared to its average volume of 6,534,314. The firm has a market capitalization of $47.29 billion, a P/E ratio of 30.72, a PEG ratio of 2.82 and a beta of 0.25. Haleon has a 1-year low of $7.89 and a 1-year high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock has a 50-day simple moving average of $9.68 and a 200-day simple moving average of $9.86.

Remove Ads

Haleon (NYSE:HLN - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. As a group, sell-side analysts expect that Haleon will post 0.43 earnings per share for the current year.

Hedge Funds Weigh In On Haleon

Hedge funds have recently bought and sold shares of the company. Brucke Financial Inc. bought a new stake in Haleon in the fourth quarter valued at $96,000. Forum Financial Management LP boosted its stake in Haleon by 52.2% in the fourth quarter. Forum Financial Management LP now owns 30,705 shares of the company's stock valued at $293,000 after acquiring an additional 10,530 shares during the last quarter. Vise Technologies Inc. boosted its stake in Haleon by 21.5% in the fourth quarter. Vise Technologies Inc. now owns 59,125 shares of the company's stock valued at $564,000 after acquiring an additional 10,468 shares during the last quarter. Principal Street Partners LLC bought a new stake in shares of Haleon in the fourth quarter valued at approximately $472,000. Finally, Wolverine Trading LLC bought a new stake in shares of Haleon in the fourth quarter valued at approximately $208,000. Institutional investors own 6.67% of the company's stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.